Saturday, October 5, 2024
HomeTagsAlzheimer’s Disease Pathology

Alzheimer’s Disease Pathology

C2N Diagnostics Says FDA’s Approval of Donanemab Highlights Its Role in Helping to Determine Alzheimer’s Disease Pathology

C2N Diagnostics, a leader in advanced brain health diagnostics, is closely tracking decision by the U.S. Food and Drug Administration to approve donanemab for...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics